Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.
$ESALY announced Keytruda combination data for Renal Cell cancer patients, refractory metastatic, like the Ovarian Cancer patients in the GPS+Key trial, and Added $9B with a B, Billion in Market cap from the 4th of June to the 7th. And it is still moving. If the GPS+Key Preliminary Results from last year are sustained, SLS will have a true and effective treatment option for Ovarian cancer patients who have none. Worth Billions.
$ESALY announced Keytruda combination data for Renal Cell cancer patients, refractory metastatic, like the Ovarian Cancer patients in the GPS+Key trial, and Added $9B with a B, Billion in Market cap from the 4th of June to the 7th. And it is still moving. If the GPS+Key Preliminary Results from last year are sustained, SLS will have a true and effective treatment option for Ovarian cancer patients who have none. Worth Billions.